Robert Iannone
Directeur Technique/Scientifique/R&D chez JAZZ PHARMACEUTICALS PLC
Fortune : 7 M $ au 30/04/2024
Postes actifs de Robert Iannone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Directeur Technique/Scientifique/R&D | 29/05/2019 | - |
| ITEOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/05/2021 | - |
| Independent Dir/Board Member | 03/05/2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Directeur/Membre du Conseil | 20/06/2023 | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Directeur Technique/Scientifique/R&D | 01/05/2019 | - |
Historique de carrière de Robert Iannone
Anciens postes connus de Robert Iannone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/01/2020 | 03/05/2023 |
| Independent Dir/Board Member | 21/01/2020 | 03/05/2023 | |
| IMMUNOMEDICS, INC. | Directeur Technique/Scientifique/R&D | 09/04/2018 | 28/05/2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/07/2014 | 01/04/2018 |
| MERCK & CO., INC. | Directeur/Membre du Conseil | 01/03/2008 | 01/07/2014 |
| Corporate Officer/Principal | 01/03/2008 | 01/07/2014 | |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | 01/01/2001 | 01/01/2012 |
Formation de Robert Iannone
| University of Pennsylvania Medical Center | Graduate Degree |
| The Catholic University of America | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Royaume-Uni | 3 |
| Irlande | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
- Bourse
- Insiders
- Robert Iannone
- Expérience
